BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37968808)

  • 1. Insulin independence following islet transplantation improves long-term metabolic outcomes.
    Stanley AK; Duncan K; Anderson D; Irvine L; Sutherland A; Forbes S; Casey J
    Diabet Med; 2024 Feb; 41(2):e15257. PubMed ID: 37968808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.
    Marfil-Garza BA; Imes S; Verhoeff K; Hefler J; Lam A; Dajani K; Anderson B; O'Gorman D; Kin T; Bigam D; Senior PA; Shapiro AMJ
    Lancet Diabetes Endocrinol; 2022 Jul; 10(7):519-532. PubMed ID: 35588757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term function (6 years) of islet allografts in type 1 diabetes.
    Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
    Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
    Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up after clinical islet transplantation.
    Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
    Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
    Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
    Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation.
    Cretin N; Caulfield A; Fournier B; Bühler L; Becker C; Philippe J; Morel P
    Transpl Int; 2001 Sep; 14(5):343-5. PubMed ID: 11692219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early metabolic markers of islet allograft dysfunction.
    Baidal DA; Faradji RN; Messinger S; Froud T; Monroy K; Ricordi C; Alejandro R
    Transplantation; 2009 Mar; 87(5):689-97. PubMed ID: 19295313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin independence following isolated islet transplantation and single islet infusions.
    Markmann JF; Deng S; Huang X; Desai NM; Velidedeoglu EH; Lui C; Frank A; Markmann E; Palanjian M; Brayman K; Wolf B; Bell E; Vitamaniuk M; Doliba N; Matschinsky F; Barker CF; Naji A
    Ann Surg; 2003 Jun; 237(6):741-9; discussion 749-50. PubMed ID: 12796569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations.
    Brooks AM; Walker N; Aldibbiat A; Hughes S; Jones G; de Havilland J; Choudhary P; Huang GC; Parrott N; McGowan NW; Casey J; Mumford L; Barker P; Burling K; Hovorka R; Walker M; Smith RM; Forbes S; Rutter MK; Amiel S; Rosenthal MJ; Johnson P; Shaw JA
    Am J Transplant; 2013 Dec; 13(12):3236-43. PubMed ID: 24119216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin independence of unstable diabetic patient after single living donor islet transplantation.
    Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K
    Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BETA-2 score is an early predictor of graft decline and loss of insulin independence after pancreatic islet allotransplantation.
    Bachul PJ; Gołębiewska JE; Basto L; Gołąb K; Anteby R; Wang LJ; Tibudan M; Thomas C; Fendler W; Lucander A; Grybowski DJ; Dębska-Ślizień A; Fung J; Witkowski P
    Am J Transplant; 2020 Mar; 20(3):844-851. PubMed ID: 31597009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study.
    Senior PA; Koh A; Yau J; Imes S; Dinyari P; Malcolm AJ; Light P; Shapiro AM
    Diabet Med; 2017 Feb; 34(2):204-212. PubMed ID: 27087519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
    Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
    Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International trial of the Edmonton protocol for islet transplantation.
    Shapiro AM; Ricordi C; Hering BJ; Auchincloss H; Lindblad R; Robertson RP; Secchi A; Brendel MD; Berney T; Brennan DC; Cagliero E; Alejandro R; Ryan EA; DiMercurio B; Morel P; Polonsky KS; Reems JA; Bretzel RG; Bertuzzi F; Froud T; Kandaswamy R; Sutherland DE; Eisenbarth G; Segal M; Preiksaitis J; Korbutt GS; Barton FB; Viviano L; Seyfert-Margolis V; Bluestone J; Lakey JR
    N Engl J Med; 2006 Sep; 355(13):1318-30. PubMed ID: 17005949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.